Ståhle L, Ljungberg T, Rodebjer A, Ogren S O, Ungerstedt U
Pharmacol Toxicol. 1987 Mar;60(3):227-32. doi: 10.1111/j.1600-0773.1987.tb01740.x.
The effects of the novel substituted benzamide remoxipride on apomorphine induced behaviour in rats was investigated by means of an automatic holeboard apparatus. The ability of remoxipride to antagonise locomotion and gnawing induced by a high dose of apomorphine (5 mg/kg) and inhibition of exploration induced by a low dose of apomorphine (0.05 mg/kg) was tested. It was found that remoxipride in moderate doses potentiate locomotion and inhibit gnawing induced by the high dose of apomorphine while higher doses of remoxipride inhibits both apomorphine induced gnawing and locomotion. The inhibition of exploration following the low dose of apomorphine was not antagonised by remoxipride pretreatment. The results demonstrated that remoxipride has an interesting and unique profile of dopamine antagonistic effects in rat behavioural models.
采用自动孔板装置研究了新型取代苯甲酰胺雷莫必利对阿扑吗啡诱导的大鼠行为的影响。测试了雷莫必利拮抗高剂量阿扑吗啡(5mg/kg)诱导的运动和啃咬以及低剂量阿扑吗啡(0.05mg/kg)诱导的探索抑制的能力。结果发现,中等剂量的雷莫必利可增强高剂量阿扑吗啡诱导的运动并抑制啃咬,而更高剂量的雷莫必利则抑制阿扑吗啡诱导的啃咬和运动。雷莫必利预处理不能拮抗低剂量阿扑吗啡后的探索抑制。结果表明,雷莫必利在大鼠行为模型中具有有趣且独特的多巴胺拮抗作用谱。